197 related articles for article (PubMed ID: 30902086)
21. Novel analogs targeting histone deacetylase suppress aggressive thyroid cancer cell growth and induce re-differentiation.
Jang S; Yu XM; Odorico S; Clark M; Jaskula-Sztul R; Schienebeck CM; Kupcho KR; Harrison AD; Winston-McPherson GN; Tang W; Chen H
Cancer Gene Ther; 2015 Aug; 22(8):410-6. PubMed ID: 26251030
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic Modifications in Thyroid Cancer Cells Restore NIS and Radio-Iodine Uptake and Promote Cell Death.
Wächter S; Damanakis AI; Elxnat M; Roth S; Wunderlich A; Verburg FA; Fellinger SA; Bartsch DK; Di Fazio P
J Clin Med; 2018 Mar; 7(4):. PubMed ID: 29561759
[TBL] [Abstract][Full Text] [Related]
23. Combination of peroxisome proliferator-activated receptor gamma and retinoid X receptor agonists induces sodium/iodide symporter expression and inhibits cell growth of human thyroid cancer cells.
Chen JY; Wang JJ; Lee HC; Chi CW; Lee CH; Hsu YC
J Chin Med Assoc; 2020 Oct; 83(10):923-930. PubMed ID: 33009242
[TBL] [Abstract][Full Text] [Related]
24. Microtransponders, the miniature RFID electronic chips, as platforms for cell growth in cytotoxicity assays.
Mandecki W; Ardelt B; Coradetti T; Davidowitz H; AFlint JA; Huang Z; MKopacka WM; Lin X; Wang Z; Darzynkiewicz Z
Cytometry A; 2006 Nov; 69(11):1097-105. PubMed ID: 17051582
[TBL] [Abstract][Full Text] [Related]
25. Development of a Microfluidic Array to Study Drug Response in Breast Cancer.
Virumbrales-Muñoz M; Livingston MK; Farooqui M; Skala MC; Beebe DJ; Ayuso JM
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801265
[TBL] [Abstract][Full Text] [Related]
26. Redifferentiation therapy in advanced thyroid cancer.
Haugen BR
Curr Drug Targets Immune Endocr Metabol Disord; 2004 Sep; 4(3):175-80. PubMed ID: 15379720
[TBL] [Abstract][Full Text] [Related]
27. Apigenin in combination with Akt inhibition significantly enhances thyrotropin-stimulated radioiodide accumulation in thyroid cells.
Lakshmanan A; Doseff AI; Ringel MD; Saji M; Rousset B; Zhang X; Jhiang SM
Thyroid; 2014 May; 24(5):878-87. PubMed ID: 24400871
[TBL] [Abstract][Full Text] [Related]
28. Cell death induction by the BH3 mimetic GX15-070 in thyroid carcinoma cells.
Broecker-Preuss M; Viehof J; Jastrow H; Becher-Boveleth N; Fuhrer D; Mann K
J Exp Clin Cancer Res; 2015 Jul; 34(1):69. PubMed ID: 26198850
[TBL] [Abstract][Full Text] [Related]
29. Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.
Broecker-Preuss M; Müller S; Britten M; Worm K; Schmid KW; Mann K; Fuhrer D
BMC Cancer; 2015 Mar; 15():184. PubMed ID: 25879531
[TBL] [Abstract][Full Text] [Related]
30. Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient.
Mulholland T; McAllister M; Patek S; Flint D; Underwood M; Sim A; Edwards J; Zagnoni M
Sci Rep; 2018 Oct; 8(1):14672. PubMed ID: 30279484
[TBL] [Abstract][Full Text] [Related]
31. The flavonoid quercetin reduces cell migration and increases NIS and E-cadherin mRNA in the human thyroid cancer cell line BCPAP.
Gonçalves CFL; Hecht F; Cazarin J; Fortunato RS; Vaisman M; Carvalho DP; Ferreira ACF
Mol Cell Endocrinol; 2021 Jun; 529():111266. PubMed ID: 33831503
[TBL] [Abstract][Full Text] [Related]
32. A Microvascularized Tumor-mimetic Platform for Assessing Anti-cancer Drug Efficacy.
Pradhan S; Smith AM; Garson CJ; Hassani I; Seeto WJ; Pant K; Arnold RD; Prabhakarpandian B; Lipke EA
Sci Rep; 2018 Feb; 8(1):3171. PubMed ID: 29453454
[TBL] [Abstract][Full Text] [Related]
33. All-trans retinoic acid suppresses malignant characteristics of CD133-positive thyroid cancer stem cells and induces apoptosis.
Mei D; Lv B; Chen B; Xiao S; Jiang J; Xie Y; Jiang L
PLoS One; 2017; 12(8):e0182835. PubMed ID: 28817605
[TBL] [Abstract][Full Text] [Related]
34. Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells.
Schwertheim S; Wein F; Lennartz K; Worm K; Schmid KW; Sheu-Grabellus SY
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1143-1154. PubMed ID: 28265769
[TBL] [Abstract][Full Text] [Related]
35. Ex vivo culture of head and neck cancer explants in cell sheet for testing chemotherapeutic sensitivity.
Lee J; You JH; Shin D; Roh JL
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2497-2507. PubMed ID: 32620987
[TBL] [Abstract][Full Text] [Related]
36. A sorafenib-sparing effect in the treatment of thyroid carcinoma cells attained by co-treatment with a novel isoflavone derivative and 1,25 dihydroxyvitamin D3.
Izkhakov E; Sharon O; Knoll E; Aizic A; Fliss DM; Kohen F; Stern N; Somjen D
J Steroid Biochem Mol Biol; 2018 Sep; 182():81-86. PubMed ID: 29702263
[TBL] [Abstract][Full Text] [Related]
37. A novel human ex vivo model for the analysis of molecular events during lung cancer chemotherapy.
Lang DS; Droemann D; Schultz H; Branscheid D; Martin C; Ressmeyer AR; Zabel P; Vollmer E; Goldmann T
Respir Res; 2007 Jun; 8(1):43. PubMed ID: 17567922
[TBL] [Abstract][Full Text] [Related]
38. Real-time and non-invasive impedimetric monitoring of cell proliferation and chemosensitivity in a perfusion 3D cell culture microfluidic chip.
Lei KF; Wu MH; Hsu CW; Chen YD
Biosens Bioelectron; 2014 Jan; 51():16-21. PubMed ID: 23920091
[TBL] [Abstract][Full Text] [Related]
39. Tunicamycin as a Novel Redifferentiation Agent in Radioiodine Therapy for Anaplastic Thyroid Cancer.
Choi YJ; Lee JE; Ji HD; Lee BR; Lee SB; Kim KS; Lee IK; Chin J; Cho SJ; Lee J; Lee SW; Ha JH; Jeon YH
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499100
[TBL] [Abstract][Full Text] [Related]
40. Sunitinib exerts only limited effects on the proliferation and differentiation of anaplastic thyroid cancer cells.
D'Agostino M; Voce P; Celano M; Sponziello M; Moretti S; Maggisano V; Verrienti A; Durante C; Filetti S; Puxeddu E; Russo D
Thyroid; 2012 Feb; 22(2):138-44. PubMed ID: 22191389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
